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Summary
Background As a major regulator of local vascular
homeostasis, the endothelium maintains vascular tone
through the balance between vasodilatation and vasocon-
striction. Upsetting this tight balance leads to endothelial
dysfunction . The latter is thought to be a marker of future
cardiovascular events in hypertensive patients.
The purpose of this research was to assess endothelial va-
somotor function with relation to heart rate variability in
adolescents with arterial hypertension.
Material and methods 56 adolescents (33 males, 23 fe-
males, aged 22 ± 2 years) were subdivided into equal
groups (regarding gender, age, body mass index and ge-
netic burden) according to hypertension appearance and
smoking habits. All of them underwent forearm
rheovasography with measurements of reactive hyperemia
test heart rate variability being taken (a five-minute re-
cording). As reliable values for evaluating endothelial func-
tion, relative changes in the peak blood flow velocity (DdZ/
/dT) and pulse blood volume (DdV) at the 1st min after
reperfusion were used.  The following parameters of the
time (RRNN, SDNN, RMSSD, pNN50, CV) and fre-
quency (TP, VLF, LF, HF; LF/HF) domain analysis were
used for assessing heart rate modulation.
Results Our analysis elicited a significant difference in both
velocity and volume characteristics between hypertensive
smokers and healthy individuals. Endothelial function in
hypertensive non-smoking patients and normotensive smo-
kers was also impaired. Heart rate variability was decreased
and sympathetic tone prevailed in hypertensive adolescents.
Both are associated with endothelial dysfunction.
Conclusions Endothelial function is likely to be impaired
in hypertensive adolescents, particularly among those who
smoke. Moreover, heart rate variability is decreased and
sympathetic tone prevails with relation to endothelial dys-
function towards the autonomic imbalance.
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Introduction
Arterial hypertension is an increasingly important
medical and public health issue. Although it is most
often considered a disease of old age, it is prone to
appear in adolescents in increasing frequencies [1],
despite important advances in our understanding of
its pathophysiology and the availability of effective
treatment strategies. Moreover, the precursors are
often present in adolescents long before the clinical-
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ly-accepted definitions of hypertension in adults are
manifested [2].
Endothelial dysfunction is thought to be a marker
of future cardiovascular events in hypertensive pa-
tients [3] since the endothelium is a major regulator
of local vascular homeostasis through synthesis and
releasing various factors that modulate angiogenesis,
hemostasis, permeability, as well as vascular tone.
Due to harmful substances in tobacco smoke
which produce oxidative stress, both acute and passi-
ve smoking is one of the most important aggressors
of endothelial function [4–13]. On the other hand,
increased sympathetic activation has been demon-
strated to also contribute to the impairment of endo-
thelial function [14, 15].
Aims and objectives
The objectives of the study were to evaluate endo-
thelial function (flow-mediated endothelium-depen-
dent vasodilation) via bioimpedance technology in ado-
lescents with arterial hypertension, as well as to reveal
associations between endothelial dysfunction and di-
sturbances in cardiovascular vegetative regulation.
Material and methods
We studied 56 persons (see tab. I) in whom no
differences were found regarding age, gender, body
mass index and genetic burden. Patients suffering
from arterial hypertension (mild to moderate) appe-
ared not to have been treated previously. Those with
blood pressure elevation due to secondary causes, or
those with concomitant pathologies, were excluded.
The study protocol was approved by the Ethics
Committee of Grodno State Medical University.
Written informed consent for participation in the stu-
dy was given by all subjects.
All of these subjects underwent forearm rheovaso-
graphy (the bioimpedance method) with a reactive
hyperemia test via the hard- software system known
as “IMPECARD”6, 16. Reactive hyperemia was pro-
duced with 50 mmHg extra being pumped into the
blood pressure cuff in order to cause an occlusion of
the brachial artery. Patients were administered or-
thophene in a dose of 25 mg, 30–40 minutes before
the examination to block prostacyclin-mediated va-
sodilation, although it appears to have a more limi-
ted role in the maintenance of vasodilator tone in
human beings than previously thought. The relative
changes of peak blood flow velocity (DdZ/dT) and
pulse blood volume (DdV) captured at the first mi-
nute following reperfusion, were considered as in-
formative parameters which highly correlate with
flow-mediated vasodilations measured sonographi-
cally. As well as the dynamics of the values were
assessed at the 3rd and 5th minutes.
Vegetative tone was assessed in compliance with
heart rate variability values [17–23] (time and frequ-
ency domain analysis, short-term recording) via
hard- and software system known as “BRIZ M”. The
following parameters were analyzed: all normal RR
intervals (RRNN), the standard deviation of all nor-
mal RR intervals (SDNN), the square root of the
mean of the squared differences between adjacent
normal RR-intervals (RMSSD), the percentage of
differences between adjacent normal RR-intervals
that are > 50 ms (pNN50), the variability coefficient
(CV), the total power of the spectrum (TP), high
frequency (HF), low frequency (LF), very low fre-
quency (VLF) components, as well as their relative
(HF%, LF%, VLF%) and normalized values
(HFnorm, LFnorm), LF/HF ratio.
All studies were performed in the morning, after
overnight fasting, in a quiet room with a constant
temperature (20–22°C) after a period of adaptation
to the environmental conditions of 10–15 minutes.
The subjects remained supine throughout the study.
The patients were requested to breath quietly, not to
move or cough. Smokers were asked not to smoke
before the examination
The statistics tools used include descriptive ones
(all data is expressed as Mean; ± 95% confidence
interval), the Mann-Whitney U test, Yates’ corrected
Table I. Characteristics of groups
Group n Gender Age Body mass Burdened Inclusion criteria Exclusion criteria
(M/F) index  heredity
1 20 6/14 22.3 ± 2.7 22.7 ± 1.3 6 Healthy individuals Age > 30 years
2 15 11/4 21.1 ± 1.3 24.5 ± 2.1  7 Nonsmoking hypertensive adolescents Secondary blood pressure elevation
3 13 8/5 22.2 ± 1.8 22.5 ± 1.7 3 Normotensive smoking persons Concomitant internal diseases
4 8 6/2 23.6 ± 2.1 23.8 ± 3.2 4 Smoking patients with Previous prolonged treatment
arterial hypertension
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chi-square and Spearman’s rank correlation co-effi-
cient (Statistica 7.0 for Windows, Statsoft Inc.). Va-
lues of p < 0.05 were considered statistically signifi-
cant.
Results
Following results were obtained (See fig. 1, 2 and
tab. II–V).
Significant correlations were found in the group
of hypertensive non-smoking adolescents for DdZ/
/dT1 and: RMSSD (R = 0.82), SDNN (R = 0.3),
pNN50 (R = 0.38), %HF (R = 0.74), %LF (R =
–0.51), LF/HF (R = –0.44) (See figs. 3–8).
Discussion
The statistical results brought out a statistically signifi-
cant difference in the rheovasographic parameters be-
tween healthy individuals and smoking adolescents with
arterial hypertension, whereas the changes observed in
other groups did not achieve a level of statistical signifi-
cance although values were lower then in controls. This
resulted from the statistical bias of small groups and the
wide range of values inside these groups. Obviously, an
association of several factors is quite more harmful in
comparison with those which are isolated. Thus, our data
confirm the results of J.A. Panza et al. [4] and F. Pertico-
ne et al. [3] who studied interactions with essential hy-
pertension, and A.M. Zeiher [13] and J. Stoner J. et al. [24]
Figure 1. Rheovasographic values at 1 minute after reperfusion
Table II. Dynamics of rheovasographic values
Parameters Time, Group 1 Group 2 Group 3 Group 4
min. Mean –95% CI +95% CI Mean –95% CI +95% CI Mean –95% CI +95% CI Mean –95% CI +95% CI
DdV (%) 1 29.9 13.4 46.4 21.0 –7.0 49.0 7.0 –9.7 23.6 –1.0 –29.3 27.3
3 18.7 4.7 32.7 13.9 1.8 26.0 –0.5 –11.3 10.2 17.8 –8.6 44.3
5 16.0 3.7 28.2 6.9 –8.0 21.9 10.3 –5.6 26.1 6.3 –14.3 26.9
DdZ/dT (%) 1 12.4 3.7 21.2 4.5 –7.2 16.3 –4.5 –17.4 8.5 –11.6 –36.3 13.1
3 2.6 –3.6 8.9 7.9 1.0 14.8 –1.0 –11.9 9.9 4.3 –12.6 21.3
5 1.7 –4.6 7.9 3.6 –3.9 11.0 –3.6 –11.7 4.6 –4.3 –14.2 5.6
nadciśnienie tętnicze rok 2008, tom 12, nr 4
294 www.nt.viamedica.pl
Table III. Criteria of endothelial dysfunction degree
Endothelial dysfunction degree Criteria
Normal DdZ/dT1 > 12%
Mild –2% < DdZ/dT1 £ 12%
Moderate –15% < DdZ/dT1 £ –2%
Severe DdZ/dT1 £ –15%
Figure 2. Distribution in groups with respect to endothelial dysfunction degree
Table IV. Endothelial reactivity patterns
Endothelial Reactivity Pattern* Group 1 Group 2 Group 3 Group 4
1 (positive) a 11 (55.0%)** 6 (40.0%) 3 (23.1%) 1 (12.5%)
b 0 (0.0%) 1 (6.7%) 2 (15.4%) 0 (0.0%)
c 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
2 (inertial, zero) a 2 (10.0%) 0 (0.0%) 0 (0.0%) 1 (12.5%)
b 1 (5.0%) 2 (13.3%) 0 (0.0%) 0 (0.0%)
c 2 (10.0%) 1 (6.7%) 2 (15.4%) 1 (12.5%)
3 (paradoxic, negative) a 1 (5.0%) 4 (26.7%) 0 (0.0%) 2 (25.0%)
b 1 (5.0%) 0 (0.0%) 3 (23.1%) 0 (0.0%)
c 2 (10.0%) 1 (6.7%) 3 (23.1%) 3 (37.5%)**
*1a — positive reaction with peak at the 1st minute; 1b — positive reaction with peak at the 3rd minute; 1c — positive reaction with peak at the 5th minute; 2a — lack of reaction at the 1st minute,
positive at the 3rd minute; 2b — lack of reaction at the 1st and 3rd minutes, positive at the 5th minute; 2c — lack of reaction within 5 minutes; 3a — negative reaction at the 1st minute, then positive at
the 3rd minute; 3b — negative reaction within 3 minutes; 3c — negative reaction within 5 minutes
**significant difference (p < 0.05, Yates corrected chi-square)
who evaluated the effects of smoking on the endothe-
lium. Moreover, we show that impedance technology is
rather suitable for endothelial function assessment.
Endothelial reactivity worsened from group 1 to
group 4 with the most frequent favorable “1a” variant
occurring in the 1st group and the poorest “3c” in the
4th. Though the Brachial Artery Reactivity Task Force
recommended 2-minutes of recording after cuff de-
flation during the reactive hyperemia test [25],
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we suggested prolonging our analysis up to 5 minu-
tes. We suppose that this determination of the reacti-
vity patterns is rather informative and useful in en-
dothelial vasomotor function testing, as it reflects the
reserve scope of the endothelium for nitric oxide se-
cretion with response to shear stress.
Table V. Heart rate variability values in the groups
Parameters Group 1 Group 2 Group 3 Group 4
Mean –95% CI +95% CI Mean –95% CI +95% CI Mean –95% CI +95% CI Mean –95% CI+95% CI
RRNN [ms] 933 754 1112 894 754 1035 899 753 1044 912 741 1083
SDNN [ms] 73.9 45.3 102.4 64.4 42.1 86.8 69.8 44.4 95.2 66.0 31.6 100.4
RMSSD [ms] 74.9 42.5 107.2 51.4 24.5 78.4 65.2 33.1 97.3 45.6 8.6 82.6
pNN50 [ms] 40.1 17.3 62.8 28.5 10.6 46.3 32.8 9.1 56.4 22.4 –2.4 47.2
CV (%) 8.1 4.6 11.6 7.1 5.0 9.2 7.9 4.4 11.4 7.1 3.8 10.4
TP [ms2] 6521 1581 11 460 5024 2129 7919 5609 1504 9714 5130 819 9441
VLF [ms2] 1954 114 3795 2373 941 3806 2180 –325 4685 2568 –423 5559
LF [ms2] 1937 70 3805 1241 713 1770 1698 326 3071 1254 –210 2718
HF [ms2] 2629 691 4567 1410 88 2731 1555 –166 3276 1308 –911 3527
VLF (%) 31.3 18.4 44.2 48.8 38.1 59.4 35.4 19.0 51.7 54.8 18.4 91.3
LF (%) 26.7 15.9 37.4 29.5 21.1 37.8 28.7 19.7 37.6 24.6 2.8 46.3
HF (%) 42.0 24.8 59.3 21.8 11.1 32.5 36.0 15.8 56.3 20.6 0.1 41.1
LF norm, n.u. 40.4 23.8 57.0 59.9 43.0 76.7 46.8 23.7 69.9 56.9 40.2 73.5
HF norm, n.u. 59.6 43.0 76.2 40.1 23.3 57.0 53.2 30.1 76.3 43.1 26.5 59.8
LF/HF 0.9 0.2 1.5 2.6 0.7 4.4 1.2 –0.1 2.4 1.5 0.7 2.3
Figure 3. Relationship between relative change of peak blood flow velocity and standard deviation of all nor-
mal RR intervals
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Figure 4. Relationship between relative change of peak blood flow velocity and square root of the mean of
the squared differences between adjacent normal RR-intervals
Figure 5. Relationship between relative change of peak blood flow velocity and percentage of differences be-
tween adjacent normal RR-intervals that are > 50 ms
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Figure 6. Relationship between relative change of peak blood flow velocity and high frequency percentage
Figure 7. Relationship between relative change of peak blood flow velocity and low frequency percentage
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Figure 8. Relationship between relative change of peak blood flow velocity and low to high frequency ratio
Normal endothelial function i.e. sufficient incre-
ase in blood flow, was obtained significantly more
often in healthy individuals, although endothelial
dysfunction was found to be present in them too. It is
possible that a variety of endogenous (such as hor-
monal baseline, etc.) and exogenous (such as mental
stress, etc.) factors, that could not be considered in
the present study, influence endothelial function.
This once again indicates the systemic features of
endothelial dysfunction as the endothelium is a re-
ceptor of a variety of stimuli. Severe dysfunction, i.e.
paradoxical vasoconstriction in response to reactive
hyperemia, was seen more often in hypertensive ado-
lescents who smoked. On the other hand, normal
function was restored in those patients who were hy-
pertensive and smoked. Thus, these lesions are proba-
bly mild, benign and potentially reversible, as the hy-
pertension was characterized with mild to moderate
elevation of blood pressure, as well as there being no
heavy smokers among the patients under observation.
Generally normal, but decreased, variability values
and increased sympathetic tone in heart rate modula-
tion were obtained in hypertensive adolescents and tho-
se who smoked. These data agree with those of D.F.
Dietrich et al. [26] who has proved heart rate variability
to be decreased in patients with passive exposure to
tobacco smoke, and A. Stys et al. [23] regarding heart
rate variability in patients suffering from arterial hyper-
tension, among other clinical applications of this me-
thod. However, our values are practically similar in all
four groups with a tendency to be impaired in the
presence of both factors. Therefore, these differences
were particularly insignificant. There was an associa-
tion between the degree of endothelial dysfunction
and decreased heart rate variability, as well as an auto-
nomic imbalance towards sympathetic prevalence in
patients with arterial hypertension, that at least, in
part, coincides with the data of Y. Takei et al. [14].
Thus, the endothelium of hypertensive adole-
scents has a decreased ability to induce vascular rela-
xation because of one, or several, mechanisms: decre-
ased synthesis, impaired response or increased inacti-
vation of NO. Hypertension-associated endothelial
dysfunction in adolescents has a strong possibility of
being reversed by a pharmacological treatment with
antihypertensive drugs. The latter may represent
a new target for therapeutic intervention in essential
hypertension. Moreover, the consideration of autono-
mic imbalance is likely to bring additional benefits.
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